Neoadjuvant Radiochemotherapy and Total Neoadjuvant Therapy in the Management of Locally Advanced Rectal Cancer. [PDF]
Yigit M +6 more
europepmc +1 more source
ABSTRACT Robotic surgery has transformed head and neck cancer (HNC) treatment. This scoping review synthesizes evidence on transoral robotic surgery (TORS), focusing on applications, limitations, and future directions. Following PRISMA‐ScR guidelines, this review used the PCC framework (Population: HNC patients; Concept: technological advancements ...
Anna Luíza Damaceno Araújo +6 more
wiley +1 more source
Selecting patients with rectal cancer for total neoadjuvant therapy based on clinical lymph node status: do we dare? [PDF]
Slipsager AB +3 more
europepmc +1 more source
ABSTRACT Pancreatic ductal adenocarcinoma (PDAC) carries a dismal prognosis despite surgical resection, yet the prognostic literature remains fragmented across hundreds of single‐institution studies that vary in design, covariates, and analytical approaches.
Muhammad Maisam Ali +8 more
wiley +1 more source
Oxaliplatin-induced neuropathy after total neoadjuvant therapy for rectal cancer: Dose-response relationship and impact on quality of life. [PDF]
Wurschi GW +29 more
europepmc +1 more source
Factors Associated With Receipt of Adjuvant Radiation in Locally Advanced Rectal Cancer
ABSTRACT Background Neoadjuvant radiotherapy (RT) has been the standard of care for locally advanced rectal cancer (LARC) for over two decades. Adjuvant RT use in LARC represents a deviation from standard care and warrants further investigation. Objectives To identify factors associated with adjuvant RT utilization.
Maryam Sherwani +4 more
wiley +1 more source
Short-Course Radiotherapy-Based Total Neoadjuvant Therapy plus Tislelizumab for Locally Advanced Rectal Cancer (Neo-STAR): Early Outcomes of a Randomized Phase II Trial. [PDF]
Wu F +32 more
europepmc +1 more source
ABSTRACT Background/Objective This study aimed to compare extreme oncoplastic surgery (EO‐partial breast reconstruction for tumors > 5 cm or multicentric lesions) with extreme reconstruction (ER‐mastectomy with reconstruction for tumors >5 cm or multicentric lesions).
Aline Regina Nunes‐Reis +4 more
wiley +1 more source
Total Neoadjuvant Therapy Outcomes and Watch-and-Wait Feasibility in Locally Advanced Rectal Cancer: A Single-Institution Retrospective Cohort Study. [PDF]
Ramanović M +6 more
europepmc +1 more source
ABSTRACT Background BREAST‐Q is the most widely used patient‐reported outcome measure following breast reconstruction, yet no consensus exists on optimal timing or duration of administration. We analyzed BREAST‐Q follow‐up after implant‐based reconstruction, comparing direct‐to‐implant (DTI) and two‐stage tissue expander (TE), to determine how outcomes
Emanuella M. Brito +8 more
wiley +1 more source

